Unitree Robotics is expected to be valued at more than 50 billion yuan – approximately $7.4 billion – following its planned initial public offering on Shanghai’s STAR Market later this month, according to valuation guidance prepared by IPO sponsor Citic Securities. The Hangzhou-based company expects first-half 2026 revenue of approximately 1.1 billion yuan, representing year-on-year growth of between 35.6% and 45.4%. Unitree plans to raise approximately 4.2 billion yuan through the IPO to expand research, development, and production.
The revenue figure and valuation guidance arrive as Unitree finalizes what would be China’s first domestic A-share listing for a pure-play humanoid robot manufacturer – a milestone the market has been anticipating since Unitree cleared its listing committee review in June.
Unitree’s Commercial Position
Unitree ranked second globally by humanoid robot installations in 2025, behind fellow Chinese company AgiBot, according to Counterpoint Research. The company has built international recognition through demonstrations of its G1 and H1 humanoids performing running, dancing, and martial arts, alongside commercial deployments spanning Japan Airlines’ baggage handling trial at Haneda Airport, the Buddhist monk ordination at Seoul’s Jogyesa Temple, the San Francisco inter-brand robot fight with EngineAI, and the first UniStore robot application marketplace.
The company’s revenue growth trajectory – from 393 million yuan in 2024 to 1.699 billion yuan in 2025, and now 1.1 billion yuan in the first half of 2026 alone – reflects accelerating commercial demand across both the G1 consumer platform and its expanding humanoid lineup.
The US Market Risk
Unitree’s IPO prospectus flagged a significant regulatory headwind. The US Federal Communications Commission last week added new foreign-produced advanced robotic devices to its Covered List, which restricts future robot models from obtaining the equipment authorizations generally required for sale in the United States. Unitree warned in its filing that the measure could affect future access to the US market, which has accounted for a meaningful share of its overseas revenue.
The FCC action is the most direct regulatory constraint on Chinese humanoid robot exports to the US to date, and follows the broader US import ban on new robots announced on July 28 and the National Defence Authorisation Act provision barring Pentagon procurement of humanoid systems from foreign adversaries. Unitree’s international expansion strategy will need to account for a US market that is progressively closing to Chinese-manufactured robotic hardware, even as other international markets – Japan, South Korea, the Middle East, and Europe – remain accessible.
The IPO, if it closes on the expected timeline this month, will establish the first liquid domestic benchmark valuation for China’s humanoid robot sector and provide Unitree with the capital to accelerate the production scaling and R&D investment that its revenue growth trajectory demands.
Disclaimer: RobotsBeat is an independent media brand owned and operated by NuvexMedia LLC, publishing news, research, and insights on artificial intelligence, emerging technologies, automation, and related industries. NuvexMedia LLC invests in and collaborates with companies across the AI, Robotics, technology, software, and digital innovation sectors. These relationships do not influence RobotsBeat's editorial coverage, and the publication maintains full editorial independence to provide accurate, timely, and objective information. © 2026 NuvexMedia LLC. All rights reserved. This content is for informational purposes only and should not be considered legal, tax, investment, financial, or other professional advice.
